MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 5, 2015, Pages E420-E429

  Ploper, Diego ^a,b   Taelman, Vincent F ^a,b,c   Robert, Lidia ^a   Perez, Brian S ^a,b,d   Titz, Björn ^b   Chen, Hsiao Wang ^b   Graeber, Thomas G ^b   Von Euw, Erika ^b   Ribas, Antoni ^a,b   De Robertis, Edward M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXIN 1; BETA CATENIN; CD63 ANTIGEN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 6; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MEMBRANE PROTEIN; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; RAB7 PROTEIN; TETRACYCLINE; UNCLASSIFIED DRUG; WNT PROTEIN; GLYCOGEN SYNTHASE KINASE 3; MITF PROTEIN, HUMAN;

ARTICLE; BIOGENESIS; BIOSYNTHESIS; CONTROLLED STUDY; ENDOLYSOSOMAL BIOGENESIS; ENDOSOME; GENE EXPRESSION; LYSOSOME; MELANOMA; MELANOMA CELL LINE; MULTIVESICULAR BODY; NONHUMAN; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION; WNT SIGNALING PATHWAY; HEK293 CELL LINE; HUMAN; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALIA;

CELL LINE, TUMOR; ENDOSOMES; GLYCOGEN SYNTHASE KINASE 3; HEK293 CELLS; HUMANS; LYSOSOMES; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; PHOSPHORYLATION; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84922311449     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1424576112     Document Type: Article

References (67)

1. MacDonald BT, Tamai K, He X (2009) Wnt/β-catenin signaling: Components, mechanisms, and diseases. Dev Cell 17(1):9-26.
2. Angers S, Moon RT (2009) Proximal events in Wnt signal transduction. Nat Rev Mol Cell Biol 10(7):468-477.
3. Clevers H, Nusse R (2012) Wnt/β-catenin signaling and disease. Cell 149(6):1192-1205.
4. Cadigan KM, Peifer M (2009) Wnt signaling from development to disease: Insights from model systems. Cold Spring Harb Perspect Biol 1(2):a002881.
5. Peifer M, Sweeton D, Casey M, Wieschaus E (1994) Wingless signal and Zeste-white 3 kinase trigger opposing changes in the intracellular distribution of Armadillo. Development 120(2):369-380.
6. Taelman VF, et al. (2010) Wnt signaling requires sequestration of glycogen synthase kinase 3 inside multivesicular endosomes. Cell 143(7):1136-1148.
7. Acebron SP, Karaulanov E, Berger BS, Huang Y-L, Niehrs C (2014) Mitotic wnt signaling promotes protein stabilization and regulates cell size. Mol Cell 54(4):663-674.
8. Bilić J, et al. (2007) Wnt induces LRP6 signalosomes and promotes dishevelleddependent LRP6 phosphorylation. Science 316(5831):1619-1622.
9. Vinyoles M, et al. (2014) Multivesicular GSK3 sequestration upon Wnt signaling is controlled by p120-catenin/cadherin interaction with LRP5/6. Mol Cell 53(3):444-457.
10. Wollert T, Hurley JH (2010) Molecular mechanism of multivesicular body biogenesis by ESCRT complexes. Nature 464(7290):864-869.
11. Hemesath TJ, et al. (1994) microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8(22):2770-2780.
12. Davis IJ, Fisher DE (2007) MiT transcription factor associated malignancies in man. Cell Cycle 6(14):1724-1729.
13. Haq R, Fisher DE (2011) Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J Clin Oncol 29(25):3474-3482.
14. Wu M, et al. (2000) c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev 14(3):301-312.
15. Ferron M, et al. (2013) A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev 27(8):955-969.
16. Packer SO (1967) The eye and skeletal effects of two mutant alleles at the microphthalmia locus of Mus musculus. J Exp Zool 165(1):21-45.
17. Hodgkinson CA, et al. (1993) Mutations at the mouse microphthalmia locus are associated with defects in a gene encoding a novel basic-helix-loop-helix-zipper protein. Cell 74(2):395-404.
18. Steingrímsson E, Copeland NG, Jenkins NA (2004) Melanocytes and the microphthalmia transcription factor network. Annu Rev Genet 38(1):365-411.
19. Garraway LA, et al. (2005) Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature 436(7047):117-122.
20. Yokoyama S, et al. (2011) A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480(7375):99-103.
21. Fuse N, Yasumoto K, Suzuki H, Takahashi K, Shibahara S (1996) Identification of a melanocyte-type promoter of the microphthalmia-associated transcription factor gene. Biochem Biophys Res Commun 219(3):702-707.
22. Sardiello M, et al. (2009) A gene network regulating lysosomal biogenesis and function. Science 325(5939):473-477.
23. Roczniak-Ferguson A, et al. (2012) The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal 5(228):ra42.
24. Settembre C, et al. (2012) A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB. EMBO J 31(5):1095-1108.
25. Martina JA, et al. (2014) The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal 7(309):ra9.
26. Dobrowolski R, et al. (2012) Presenilin deficiency or lysosomal inhibition enhances Wnt signaling through relocalization of GSK3 to the late-endosomal compartment. Cell Reports 2(5):1316-1328.
27. Settembre C, Ballabio A (2011) TFEB regulates autophagy: An integrated coordination of cellular degradation and recycling processes. Autophagy 7(11):1379-1381.
28. Cohen P, Frame S (2001) The renaissance of GSK3. Nat Rev Mol Cell Biol 2(10):769-776.
29. Subramanian A, et al. (2005) Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545-15550.
30. Hoek KS, et al. (2008) Novel MITF targets identified using a two-step DNA microarray strategy. Pigment Cell Melanoma Res 21(6):665-676.
31. Settembre C, et al. (2013) TFEB controls cellular lipid metabolism through a starva-tion-induced autoregulatory loop. Nat Cell Biol 15(6):647-658.
32. Alonso-Curbelo D, et al. (2014) RAB7 controls melanoma progression by exploiting a lineage-specific wiring of the endolysosomal pathway. Cancer Cell 26(1):61-76.
33. Palmieri M, et al. (2011) Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum Mol Genet 20(19):3852-3866.
34. O'Connell MP, Weeraratna AT (2009) Hear the Wnt Ror: How melanoma cells adjust to changes in Wnt. Pigment Cell Melanoma Res 22(6):724-739.
35. Li VSW, et al. (2012) Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 149(6):1245-1256.
36. Du J, et al. (2003) MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma. Am J Pathol 163(1):333-343.
37. Hoek KS, et al. (2008) In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68(3):650-656.
38. Ibarrola-Villava M, et al. (2014) Genes involved in the WNT and vesicular trafficking pathways are associated with melanoma predisposition. Int J Cancer, 10.1002/ ijc.29257.
39. Strub T, et al. (2011) Essential role of microphthalmia transcription factor for DNA replication, mitosis and genomic stability in melanoma. Oncogene 30(20):2319-2332.
40. Levy C, Khaled M, Fisher DE (2006) MITF: Master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 12(9):406-414.
41. Raposo G, Tenza D, Murphy DM, Berson JF, Marks MS (2001) Distinct protein sorting and localization to premelanosomes, melanosomes, and lysosomes in pigmented melanocytic cells. J Cell Biol 152(4):809-824.
42. Raposo G, Marks MS (2007) Melanosomes-Dark organelles enlighten endosomal membrane transport. Nat Rev Mol Cell Biol 8(10):786-797.
43. Basrur V, et al. (2003) Proteomic analysis of early melanosomes: Identification of novel melanosomal proteins. J Proteome Res 2(1):69-79.
44. Chi A, et al. (2006) Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes. J Proteome Res 5(11):3135-3144.
45. Martina JA, Diab HI, Li H, Puertollano R (2014) Novel roles for the MiTF/TFE family of transcription factors in organelle biogenesis, nutrient sensing, and energy homeostasis. Cell Mol Life Sci 71(13):2483-2497.
46. Kallunki T, Olsen OD, Jäättelä M (2013) Cancer-associated lysosomal changes: Friends or foes? Oncogene 32(16):1995-2004.
47. Valsesia A, et al. (2011) Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma. PLoS ONE 6(4):e18369.
48. Arozarena I, et al. (2011) In melanoma, beta-catenin is a suppressor of invasion. Oncogene 30(45):4531-4543.
49. Chien AJ, et al. (2009) Activated Wnt/β-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 106(4):1193-1198.
50. Kageshita T, et al. (2001) Loss of β-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 145(2):210-216.
51. Biechele TL, et al. (2012) Wnt/β -catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma. Sci Signal 5(206):ra3.
52. Lucero OM, Dawson DW, Moon RT, Chien AJ (2010) A re-evaluation of the "oncogenic" nature of Wnt/β-catenin signaling in melanoma and other cancers. Curr Oncol Rep 12(5):314-318.
53. Kim N-G, Xu C, Gumbiner BM (2009) Identification of targets of the Wnt pathway destruction complex in addition to β-catenin. Proc Natl Acad Sci USA 106(13): 5165-5170.
54. Dorsky RI, Raible DW, Moon RT (2000) Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev 14(2): 158-162.
55. Takeda K, et al. (2000) Induction of melanocyte-specific microphthalmia-associated transcription factor by Wnt-3a. J Biol Chem 275(19):14013-14016.
56. Hsiao JJ, Fisher DE (2014) The roles of microphthalmia-associated transcription factor and pigmentation in melanoma. Arch Biochem Biophys 563:28-34.
57. Bertolotto C, et al.; French Familial Melanoma Study Group (2011) A SUMOylationdefective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480(7375):94-98.
58. Arnheiter H, et al. (2007) MITF-A matter of life and death for developing melanocytes. From Melanocytes to Melanoma: The Progression to Malignancy, eds Hearing VJ, Leong SPL (Humana, Totowa, NJ), pp 27-49.
59. Takeda K, et al. (2000) Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Hum Mol Genet 9(1): 125-132.
60. Palmieri G, et al. (2009) Main roads to melanoma. J Transl Med 7(1):86.
61. Wellbrock C, Marais R (2005) Elevated expression of MITF counteracts B-RAF-stimulated melanocyte and melanoma cell proliferation. J Cell Biol 170(5):703-708.
62. Garraway LA, Lander ES (2013) Lessons from the cancer genome. Cell 153(1):17-37.
63. Carreira S, et al. (2006) Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 20(24):3426-3439.
64. Hoek KS, Goding CR (2010) Cancer stem cells versus phenotype-switching in melanoma. Pigment Cell Melanoma Res 23(6):746-759.
65. Cheli Y, et al. (2011) Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny. Oncogene 30(20):2307-2318.
66. Sáez-Ayala M, et al. (2013) Directed phenotype switching as an effective antimelanoma strategy. Cancer Cell 24(1):105-119.
67. Meijer L, et al. (2003) GSK-3-selective inhibitors derived from Tyrian purple indirubins. Chem Biol 10(12):1255-1266.